Cargando…
Use of Dendritic Cell Receptors as Targets for Enhancing Anti-Cancer Immune Responses
A successful anti-cancer vaccine construct depends on its ability to induce humoral and cellular immunity against a specific antigen. Targeting receptors of dendritic cells to promote the loading of cancer antigen through an antibody-mediated antigen uptake mechanism is a promising strategy in cance...
Autores principales: | Hossain, Md Kamal, Wall, Katherine A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469018/ https://www.ncbi.nlm.nih.gov/pubmed/30909630 http://dx.doi.org/10.3390/cancers11030418 |
Ejemplares similares
-
Liposomal Fc Domain Conjugated to a Cancer Vaccine
Enhances Both Humoral and Cellular Immunity
por: Hossain, Md Kamal, et al.
Publicado: (2019) -
Augmenting Vaccine Immunogenicity through the Use
of Natural Human Anti-rhamnose Antibodies
por: Hossain, Md Kamal, et al.
Publicado: (2018) -
Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines
por: Hossain, Md Kamal, et al.
Publicado: (2016) -
In vitro enhancement of dendritic cell-mediated anti-glioma immune response by graphene oxide
por: Wang, Wei, et al.
Publicado: (2014) -
Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
por: Ohshio, Yasuhiko, et al.
Publicado: (2015)